Our expertise in early stages of integrated drug discovery – hit identification, hit-to-lead, and lead optimization – combines fluorescence-based assays that we invented with advanced tools for rapid data acquisition and reporting. Our collection of services includes ion channel and GPCR-focused assay development, high-throughput screening, cell engineering, cell-based assays, and more. Whether you need a single service or a comprehensive package, we can offer you competitive prices and fast turnaround times as a specialty contract research organization. Contact us today to speak with an expert.